| Literature DB >> 33503913 |
Katerina Gioti1, Anastasia Papachristodoulou1,2, Dimitra Benaki2, Nektarios Aligiannis3, Alexios-Leandros Skaltsounis3, Emmanuel Mikros2, Roxane Tenta1.
1. Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Kallithea, 17671 Athens, Greece.
2. Department of Pharmacy, Section of Pharmaceutical Chemistry, National and Kapodostrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece.
3. Department of Pharmacy, Section of Pharmacognosy and Natural Products Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece.
Abstract
Entities:
Keywords: adriamycin; oleuropein; osteosarcoma
Mesh:
Anti-Infective Agents/pharmacology
Antibiotics, Antineoplastic/pharmacology
Cell Proliferation/drug effects
Cell Survival/drug effects
Cytotoxins/pharmacology
Dietary Supplements
Doxorubicin/pharmacology
Humans
Iridoids/pharmacology
Osteosarcoma/drug therapy
Tumor Cells, Cultured
Substances:
Anti-Infective Agents
Antibiotics, Antineoplastic
Cytotoxins
Iridoids
oleuropein
Doxorubicin
Year: 2021 PMID: 33503913 PMCID: PMC7911555 DOI: 10.3390/nu13020354
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717